Evaluation of the First Contact Physiotherapy (FCP) model of primary care: patient characteristics and outcomes.


Journal

Physiotherapy
ISSN: 1873-1465
Titre abrégé: Physiotherapy
Pays: England
ID NLM: 0401223

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 27 08 2020
revised: 16 06 2021
accepted: 02 08 2021
pubmed: 18 10 2021
medline: 26 2 2022
entrez: 17 10 2021
Statut: ppublish

Résumé

First Contact Physiotherapy (FCP) is a primary care model where expert musculoskeletal (MSK) physiotherapists undertake the first patient consultation, to enhance MSK-patient care and free-up GP capacity. The authors report the quantitative findings from the FCP National Evaluation (Phase 3) which evaluated the FCP model against success criteria. A mixed-methods 24-month service evaluation involving 40 FCP sites and 240 FCPs across England. An online platform collected patient-reported experience and outcomes following the FCP consultation and at 1, 2 and 3-months follow-up. These included the Keele STarT MSK Tool, pain intensity (0-10 NRS scale), Musculoskeletal Health Questionnaire (MSK-HQ, range 0-56), and Friends-and-Family Test. Over 13 months, 2825 patients were invited by email and 24% (n=680) completed their initial questionnaire. Their mean age was 56.2 (SD 14.9), 61% were female, ethnicity was 97% white, mean pain intensity was 6.1 (SD 2.13) and mean MSK-HQ score was 33.8 (SD 9.5). At 3-months follow-up (n=370) there was a 2.8 (CI 2.5 to 3.1) mean pain intensity reduction from baseline, a mean 7.1 (6.0 to 8.2) score improvement in MSK-HQ and 64% reporting overall improvement (much better/better) since seeing the FCP. One of the six success criteria was not met; 29% of those in employment reported receiving specific work advice from the FCP (target ≥75%). Ahead of the planned scale-up of the FCP primary care model across the UK, this evaluation provides useful data on patients who access this service, their short-term clinical outcomes and whether key success criteria are being met.

Identifiants

pubmed: 34656297
pii: S0031-9406(21)00074-2
doi: 10.1016/j.physio.2021.08.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-208

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

S Stynes (S)

Keele University, School of Medicine, Primary Care Centre Versus Arthritis, Keele, United Kingdom; Midlands Partnership Foundation NHS Trust, Haywood Hospital Spinal Interface Service, Staffordshire, United Kingdom. Electronic address: s.stynes@keele.ac.uk.

K P Jordan (KP)

Keele University, School of Medicine, Primary Care Centre Versus Arthritis, Keele, United Kingdom. Electronic address: k.p.jordan@keele.ac.uk.

J C Hill (JC)

Keele University, School of Medicine, Primary Care Centre Versus Arthritis, Keele, United Kingdom. Electronic address: j.hill@keele.ac.uk.

G Wynne-Jones (G)

Keele University, School of Medicine, Primary Care Centre Versus Arthritis, Keele, United Kingdom. Electronic address: g.wynne-jones@keele.ac.uk.

E Cottrell (E)

Keele University, School of Medicine, Primary Care Centre Versus Arthritis, Keele, United Kingdom. Electronic address: e.cottrell@keele.ac.uk.

N E Foster (NE)

Keele University, School of Medicine, Primary Care Centre Versus Arthritis, Keele, United Kingdom; Faculty of Health and Behavioural Sciences, University of Queensland, Australia. Electronic address: n.foster@uq.edu.au.

R Goodwin (R)

Division of Rehabilitation, Ageing and Wellbeing, Faculty of Medicine & Health Sciences, University of Nottingham, United Kingdom. Electronic address: rob.goodwin@nottingham.ac.uk.

A Bishop (A)

Keele University, School of Medicine, Primary Care Centre Versus Arthritis, Keele, United Kingdom. Electronic address: a.bishop@keele.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH